Female CEOs
Health
Pharmaceutical

Editas Medicine

10,324

$19.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.48 (+8.00%) Today
-$0.01 (-0.05%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell EDIT and other stocks, options, ETFs, and crypto commission-free!

About EDIT

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). Read More The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.

CEO
Cynthia L. Collins
Employees
208
Headquarters
Cambridge, Massachusetts
Founded
2013
Market Cap
1.10B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.32M
High Today
$20.00
Low Today
$18.20
Open Price
$18.50
Volume
676.23K
52 Week High
$34.37
52 Week Low
$14.01

Collections

Female CEOs
Health
Pharmaceutical
Therapy
Medical
Technology
Biotechnology
2016 IPO

EDIT Earnings

-$0.74
-$0.49
-$0.25
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 5, After Hours

People Also Bought

CRISPR

29,814

$39.82

+3.43%

CRISPR

29,814

$39.82

+3.43%

Intellia Therapeutics

5,196

$11.94

+7.18%

Sangamo Therapeutics

7,492

$6.82

+9.82%

Illumina

4,962

$272.99

+6.45%

You May Also Like

JOUT
CLNY-B
DX
PTNR
CVCO
FTACW
RMTI
TDA
BLDR
TKAT
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy EDIT

Market Price$19.97
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell EDIT stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up